更新院内心脏骤停风险标化生存率模型以促进医院间比较
在Get With The Guidelines®-Resuscitation数据库内,研究纳入2020年3月至2021年12月(COVID-19疫情时期)53,922例成人院内心脏骤停(IHCA)患者,采用层次logistic回归建立并验证了更新的出院生存风险标化生存率(RSSR)模型。推导队列生存率为21.0%,验证队列为20.8%;模型判别能力良好(C统计量0.72),校准优秀。更新后的精简模型包含13个变量——原模型全部9个预测变量及4个新增预测变量(包括COVID-19感染状态)。将更新模型应用于2018—2019年疫情前数据时,更新模型与既往模型所得RSSR高度相关(r=0.993)。更新模型可用于支持医院间基准比较及利用COVID-19出现前后数据的研究。
要点
- 在2020年3月至2021年12月COVID-19疫情期间53,922例成人IHCA中,推导队列出院生存率21.0%,验证队列20.8%。
- 更新RSSR模型判别能力良好(C统计量0.72),校准优秀,含13个变量,包括COVID-19感染状态。
- 应用于2018—2019年疫情前数据时,更新模型与既往模型所得RSSR高度相关(r=0.993)。
- 更新模型可用于支持医院间基准比较及利用COVID-19出现前后数据的研究。
适用人群与场景
- Get With The Guidelines®-Resuscitation数据库中2020年3月至2021年12月(COVID-19疫情时期)的成人IHCA患者,共53,922例,用于推导和验证更新RSSR模型。
研究设计与关键结果
- 研究类型:在Get With The Guidelines®-Resuscitation数据库内建立并验证更新RSSR模型,采用层次logistic回归,比较更新模型与既往模型的性能。
- 研究人群与样本量:2020年3月至2021年12月(COVID-19疫情时期)成人IHCA患者53,922例。
- 主要终点结果:推导队列出院生存率21.0%,验证队列20.8%;模型判别能力良好(C统计量0.72),校准优秀。
- 模型构成:更新后的精简模型含13个变量——原模型全部9个预测变量及4个新增预测变量,包括COVID-19感染状态。
- 与既往模型比较:应用于2018—2019年疫情前数据时,更新模型与既往模型所得RSSR高度相关(r=0.993)。
证据类型、等级与局限
- 证据类型:基于Get With The Guidelines®-Resuscitation数据库的模型推导与验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 更新模型可用于支持医院间IHCA生存率基准比较的持续工作,并可支持使用COVID-19出现前后数据的研究。
- 对于疫情前(2018—2019年)的IHCA数据,更新模型所得RSSR与既往模型高度相关(r=0.993)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Risk-standardized survival rates (RSSR) for in-hospital cardiac arrest (IHCA) have been widely used for hospital benchmarking and research. The novel coronavirus 2019 (COVID-19) pandemic has led to a substantial decline in IHCA survival as COVID-19 infection is associated with markedly lower survival. Therefore, there is a need to update the model for computing RSSRs for IHCA given the COVID-19 pandemic.
METHODS: Within Get With The Guidelines®-Resuscitation, we identified 53,922 adult patients with IHCA from March, 2020 to December, 2021 (the COVID-19 era). Using hierarchical logistic regression, we derived and validated an updated model for survival to hospital discharge and compared the performance of this updated RSSR model with the previous model.
RESULTS: The survival rate was 21.0% and 20.8% for the derivation and validation cohorts, respectively. The model had good discrimination (C-statistic 0.72) and excellent calibration. The updated parsimonious model comprised 13 variables-all 9 predictors in the original model as well as 4 additional predictors, including COVID-19 infection status. When applied to data from the pre-pandemic period of 2018-2019, there was a strong correlation (r = 0.993) between RSSRs obtained from the updated and the previous models.
CONCLUSION: We have derived and validated an updated model to risk-standardize hospital rates of survival for IHCA. The updated model yielded RSSRs that were similar to the initial model for IHCAs in the pre-pandemic period and can be used for supporting ongoing efforts to benchmark hospitals and facilitate research that uses data from either before or after the emergence of COVID-19.
参考来源
- Chan PS, Kennedy KF, Girotra S, et al. Updating the model for Risk-Standardizing survival for In-Hospital cardiac arrest to facilitate hospital comparisons. Resuscitation. 2023. PMID: 36610502. doi:10.1016/j.resuscitation.2022.109686
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。